- Home
- CHD
as 07-26-2024 4:00pm EST
Church & Dwight is the leading global producer of baking soda. Beyond baking soda, the products in its portfolio have a vast category reach, including laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Batiste, OxiClean, Vitafusion, WaterPik, Hero, and TheraBreath, which together with Arm & Hammer constitute around 70% of its annual sales and profits. Even as it works to extend the reach of its products, Church & Dwight still derives more than 80% of its sales from its home market in the US.
Upcoming Earnings Alert:
Get ready for potential market movements as Church & Dwight Company Inc. CHD prepares to release earnings report on 02 Aug 2024.
| Founded: | 1846 | Country: | United States |
| Employees: | N/A | City: | EWING |
| Market Cap: | 26.0B | IPO Year: | N/A |
| Target Price: | $105.28 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Hold | Number of Analysts: | 20 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.15 | EPS Growth: | 88.62 |
| 52 Week Low/High: | $82.25 - $110.31 | Next Earning Date: | 08-02-2024 |
| Revenue: | $5,941,400,000 | Revenue Growth: | 7.86% |
| Revenue Growth (this year): | 5.51% | Revenue Growth (next year): | 3.97% |
Stock Insider Trading Activity of Church & Dwight Company Inc. (CHD)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hooker Carlen | CHD | EVP, Chief Commercial Officer | Jun 14 '24 | Sell | $106.71 | 2,500 | $266,777.50 | 0 | SEC Form 4 |
| SHEARER ROBERT K | CHD | Director | May 8 '24 | Sell | $106.36 | 13,200 | $1,403,990.28 | 29,108 | SEC Form 4 |
| Price Penry W | CHD | Director | May 6 '24 | Sell | $105.47 | 7,752 | $817,608.09 | 25,692 | SEC Form 4 |
| Read Michael | CHD | EVP, International | Mar 11 '24 | Sell | $105.00 | 4,500 | $472,500.00 | 0 | SEC Form 4 |
| Buchert Brian D | CHD | EVP of Strategy, M&A, and BP | Mar 6 '24 | Sell | $102.84 | 6,000 | $617,014.20 | 0 | SEC Form 4 |
| Buchert Brian D | CHD | EVP of Strategy, M&A, and BP | Mar 6 '24 | Sell | $102.84 | 6,120 | $629,354.48 | 0 | SEC Form 4 |
| Read Michael | CHD | EVP, International | Mar 4 '24 | Sell | $100.95 | 9,000 | $908,577.00 | 0 | SEC Form 4 |
| Price Penry W | CHD | Director | Feb 9 '24 | Sell | $98.29 | 7,752 | $761,951.83 | 25,692 | SEC Form 4 |
| WINKLEBLACK ARTHUR B | CHD | Director | Feb 5 '24 | Sell | $99.30 | 12,960 | $1,286,902.08 | 7,129 | SEC Form 4 |
| Read Michael | CHD | EVP, International | Nov 30 '23 | Sell | $96.00 | 4,500 | $432,000.00 | 0 | SEC Form 4 |
Latest Church & Dwight Company Inc. News
CHD Breaking Stock News: Dive into CHD Ticker-Specific Updates for Smart Investing
Zacks
10 hours ago
Church & Dwight (CHD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Zacks
a day ago
Will Church & Dwight (CHD) Beat Estimates Again in Its Next Earnings Report?
TipRanks
2 days ago
‘Expect Continued Outperformance,’ Says Cowen About These 2 Household Stocks
MT Newswires
4 days ago
TD Cowen Initiates Church & Dwight at Buy With $116 Price Target
Zacks
4 days ago
Here's Why Church & Dwight (CHD) is a Strong Growth Stock
Zacks
4 days ago
Newell (NWL) Gears Up for Q2 Earnings: What You Should Know
MT Newswires
4 days ago
BNP Paribas Exane Adjusts Price Target on Church & Dwight to $110 From $114
Zacks
7 days ago
Keurig Dr Pepper (KDP) to Report Q2 Earnings: What's in Store?
Compare CHD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHD Church & Dwight Company Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.